Table 1 Participant demographics.

From: Preservation of explicit learning of visuomotor sequences during Parkinson’s disease progression

Characteristic

PD patients

Controls

F

P

Test used

Stage II

(n = 8)

Stage III

(n = 10)

Stage IV

(n = 5)

(n = 17)

Gender (M/F)

5/3

5/5

2/3

10/7

   

Age (years)

63.2 ± 5.5

62.8 ± 7.2

61.0 ± 8.5

63.2 ± 5.5

0.301

0.824

ANOVA

MMSE

27.9 ± 1.5

28.3 ± 1.5

28.4 ± 1.5

28.6 ± 1.1

 

0.6

KW

Duration of PD (years)

7.3 ± 4.5

7.3 ± 3.8

13.8 ± 9.6

  

0.19

KW

UPDRS motor section

14.4** ± 5.9

22.3* ± 8.9

35.4 ± 7.3

 

11.7

<0.001

ANOVA

LLED (mg/day)

437.5 ± 240.1

445.0 ± 231.5

550.0 ± 316.2

 

0.359

0.703

ANOVA

  1. Values are means ± SD. KW: Kruskal Wallis test. *P < 0.05 compared to Stage IV. **P < 0.01 compared to Stage IV.